158429-58-4 Usage
Uses
Used in Pharmaceutical Industry:
3-(Cyclopentyloxy)-4-methoxybenzamide is used as a pharmaceutical candidate for the development of new drugs, leveraging its potential to modulate biological processes. Its unique structure allows it to interact with receptors or enzymes, which may contribute to the treatment of various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-(cyclopentyloxy)-4-methoxybenzamide is used as a research compound to explore its interactions with biological systems. This helps scientists understand its specific biological activity and identify potential pharmacological uses, paving the way for the development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 158429-58-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,4,2 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 158429-58:
(8*1)+(7*5)+(6*8)+(5*4)+(4*2)+(3*9)+(2*5)+(1*8)=164
164 % 10 = 4
So 158429-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H17NO3/c1-16-11-7-6-9(13(14)15)8-12(11)17-10-4-2-3-5-10/h6-8,10H,2-5H2,1H3,(H2,14,15)
158429-58-4Relevant academic research and scientific papers
COMPOUNDS CONTAINING PHENYL LINKED TO ARYL OR HETEROARYL BY AN ALIPHATIC- OR HETEROATOM-CONTAINING LINKING GROUP
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
-
, (2008/06/13)
This invention is directed to the pharmaceutical use of phenyl compounds, which are linked to an aryl moiety by various linkages, for inhibiting tumor necrosis factor. The invention is also directed to the compounds, their preparation and pharmaceutical compositions containing these compounds. Furthermore, this invention is directed to the pharmaceutical use of the compounds for inhibiting cyclic AMP phosphodiesterase.
